Patients’ effective doses assessment during low-dose computed tomography

Abstract

Computed tomography has become increasingly common for diagnosing socially significant diseases in recent years. In foreign practice, screening schemes for lung cancer in people belonging to risk categories have been developed and implemented. These schemes have been successfully used over the past 10 years. In this case, “low-dose” scanning protocols are used, which make it possible to perform examination with patient effective dose several times lower compared to standard protocols. Lung cancer screening methods using low-dose computed tomography are beginning to be introduced in the Russian Federation. To ensure the radiation safety of those individuals eligible for inclusion in screening programs or participating in biomedical research testing lung cancer screening, it is necessary to evaluate effective doses from low-dose computed tomography and compare these doses to established radiation dose limits. This study assessed the patients’ effective doses who underwent different types of low-dose computed tomography of chest at two medical organizations. The results of the study show that it is possible to achieve non-exceedance of the current annual effective dose limit of 1 mSv only for patients weighing less than 90 kg. For patients with higher body weight, the minimum effective dose will be in the range of 1.2 – 1.4 mSv. The results of the study indicate the need to make changes to the current regulatory and methodological documents of Rospotrebnadzor to ensure the possibility of using low-dose computed tomography as part of screening for all categories of people.

Keywords

• low-dose computed tomography
• effective dose
• lung cancer screening
• screening examination